Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease

American Journal of Surgical Pathology

Volumn 27, Issue 1, 2003, Pages 91-100

  Amin, Hesham M ^a   Medeiros, L Jeffrey ^a   Manning, John T ^a   Jones, Dan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fibroblast; Germinal center; Herpesvirus; Mantle zone

Indexed keywords

GROWTH FACTOR RECEPTOR;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; GERMINAL CENTER; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOBLAST; IMMUNOPHENOTYPING; LYMPH FOLLICLE; LYMPH NODE BIOPSY; LYMPHOCYTE; MALE; PATHOGENESIS; PLASMA CELL; PLASMACYTOSIS; VIRUS INFECTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; DNA, VIRAL; GERMINAL CENTER; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PLASMA CELLS; POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI;

EID: 0037215356     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200301000-00010     Document Type: Article

References (51)

1. Abdel-Reheim FA, Koss W, Rappaport ES, et al. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease). Arch Pathol Lab Med 1996;120:91-6.
2. Amin HM, McLaughlin P, Rutherford C, et al. Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States. Am J Dermatopathol 2002;24:241-5.
3. An J, Lichtenstein AK, Brent G, et al. The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: Role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood 2002;99:649-54.
4. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 1999;93:4034-43.
5. Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86-9.
6. Beck JT, Hsu SM, Wijdenes J, et al. Brief report: Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994;330:602-5.
7. Benelli R, Barbero A, Buffa A, et al. Distinct chemotactic and angiogenic activities of peptides derived from Kaposi's sarcoma virus encoded chemokines. Int J Oncol 2000;17:75-81.
8. Burger R, Wendler J, Antoni K, et al. Interleukin-6 production in B-cell neoplasias and Castleman's disease: Evidence for an additional paracrine loop. Ann Hematol 1994;69:25-31.
9. Cannon JS, Nicholas J, Orenstein JM, et al. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis 1999; 180:824-8.
10. Castleman B, Iverson L, Menendz VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956;9: 822-30.
11. Cesarman E. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent Results Cancer Res 2002;159:27-37.
12. Chan AC, Chan KW, Chan JK, et al. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: Tracing its evolution by sequential biopsies. Histopathology 2001;38:510-8.
13. Cokelaere K, Debiec-Rychter M, De Wolf-Peeters C, et al. Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: Molecular evidence of mesenchymal tumorigenesis. Am J Surg Pathol 2002;26:662-9.
14. Cosgaya JM, Shooter EM. Binding of nerve growth factor to its p75 receptor in stressed cells induces selective IkappaB-beta degradation and NF-kappaB nuclear translocation. J Neurochem 2001; 79:391-9.
15. d'Agay MF, Miclea JM, Clauvel JP, et al. Castleman's disease: A well defined histological pattern for a widely divergent clinical spectrum. Nouv Rev Fr Hematol 1989;31:145-8.
16. Danon AD, Krishnan J, Frizzera G. Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: With emphasis on a stroma-rich variant and a new pathogenetic hypothesis. Virchows Arch A Pathol Anat Histopathol 1993;423:369-82.
17. Drut R, Larregina A. Angiofollicular lymph node transformation in Hodgkin's lymphoma. Pediatr Pathol 1991;11:903-8.
18. Du MQ, Liu H, Diss TC, et al. Kaposi sarcoma-associated herpes-virus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001;97:2130-6.
19. Dupin N. Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000;95:1406-12.
20. Fanburg-Smith JC, Miettinen M. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other non-neural tumors: A study of 1,150 tumors and fetal and adult normal tissues. Hum Pathol 2001;32:976-83.
21. Feigert JM, Sweet DL, Coleman M, et al. Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women: A distinct syndrome. Ann Intern Med 1990;113:362-7.
22. Foss HD, Araujo I, Demel G, et al. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol 1997;183:44-50.
23. Hall PA, Donaghy M, Cotter FE, et al. An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology 1989;14:333-46; discussion 429-32.
24. Holst PJ, Rosenkilde MM, Manfra D, et al. Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. J Clin Invest 2001;108: 1789-96.
25. Jones D. Dismantling the germinal center: Comparing the processes of transformation, regression, and fragmentation of the lymphoid follicle. Adv Anat Pathol 2002;9:129-38.
26. Jones D, Ballestas ME, Kaye KM, et al. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med 1998;339:444-9.
27. Jones D. Jorgensen JL, Shahsafaei A, et al. Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol 1998;22:956-64.
28. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-83.
29. Lin O, Frizzera G. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: A study of 10 cases. Am J Surg Pathol 1997;21:1295-306.
30. Maheswaran PR, Ramsay AD, Norton AJ, et al. Hodgkin's disease presenting with the histological features of Castleman's disease. Histopathology 1991;18:249-53.
31. Masood R, Cesarman E, Smith DL, et al. Human herpesvirus-8- transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol 2002;160:23-30.
32. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: A comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol 1992;5:525-30.
33. Menke DM, Chadbum A, Cesarman E, et al. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of Castleman disease at low risk for HIV infection. Am J Clin Pathol 2002;117:268-75.
34. Menke DM, Tiemann M, Camoriano JK, et al. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol 1996;105: 268-76.
35. Molinie V, Diebold J, Perie G. Hodgkin's disease associated with localized or multicentric Castleman's disease. Arch Pathol Lab Med 1995;119:201.
36. Neipel F, Albrecht JC, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 1997;71:839-42.
37. Nguyen DT, Diamond LW, Hansmann ML, et al. Castleman's disease: Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology 1994;24: 437-43.
38. Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 2000;95:56-61.
39. Ohyashiki JH, Ohyashiki K, Kawakubo K, et al. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type. Am J Clin Pathol 1994;101:290-5.
40. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002;99:2331-6.
41. Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 2000;96: 2069-73.
42. Oksenhendler E, Cazals-Hatem D, Schulz TF. et al. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med 1998;338:1585-90.
43. Oksenhendler E, Duarte M, Soulier J, et al. Multicentric Castleman's disease in HIV infection: A clinical and pathological study of 20 patients. AIDS 1996;10:61-7.
44. Pauwels P, Dal Cin P, Vlasveld LT, et al. A chromosomal abnormality in hyaline vascular Castleman's disease: Evidence for clonal proliferation of dysplastic stromal cells. Am J Surg Pathol 2000; 24:882-8.
45. Perini G, Della-Bianca V, Politi V, et al. Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 2002;195: 907-18.
46. Radaszkiewicz T, Hansmann ML, Lennert K. Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant. Histopathology 1989;14:11-24.
47. Raymond I, Al Saati T, Tkaczuk J, et al. CNA.42, a new monoclonal antibody directed against a fixative-resistant antigen of follicular dendritic reticulum cells. Am J Pathol 1997;151:1577-85.
48. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
49. Vega F, Medeiros LJ, Lang W, et al. The stromal composition of malignant lymphoid aggregates in bone marrow: Variations in architecture and phenotype in different B-cell tumors. Br J Haematol 2002;117:569-76.
50. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-7.
51. Zarate-Osorno A, Medeiros LJ, Danon AD, et al. Hodgkin's disease with coexistent Castleman-like histologic features: A report of three cases. Arch Pathol Lab Med 1994;118:270-4.